Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 105, Issue 6, 1998, Pages 632-640

  Knight, Marian ^a   Redman, Christopher W G ^a   Linton, Elizabeth A ^a   Sargent, Ian L ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CELL PROLIFERATION; CESAREAN SECTION; CLINICAL ARTICLE; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; FLUOROIMMUNOASSAY; HUMAN; MICROVILLUS; PREECLAMPSIA; PRIORITY JOURNAL; SYNCYTIOTROPHOBLAST; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

ADULT; ENDOTHELIUM, VASCULAR; FEMALE; FLOW CYTOMETRY; FLUOROIMMUNOASSAY; HUMANS; MICROVILLI; PRE-ECLAMPSIA; PREGNANCY; TROPHOBLASTS; VASCULAR DISEASES;

EID: 0031799092     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1998.tb10178.x     Document Type: Article

References (26)

1. Roberts JM, Taylor RN, Musci TJ et al. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol P 1989; 161: 1200–1204.
2. Scott JS. Pregnancy toxaemia associated with hydrops foetalis, hydatidiform mole and hydramnios. J Obstet Gynaecol Br Emp 1958; 65: 689–701.
3. Smarason AK, Sargent IL, Starkey PM, Redman CW. The effect of placental syncytiotrophoblast microvillous membranes from normal and pre-eclamptic women on the growth of endothelial cells in vitro. Br J Obstet Gynaecol 1993; 100: 943–949.
4. Cockell AP, Learmont JG, Smarason AK et al. Human placental syncytiotrophoblast microvillous membranes impair maternal vascular endothelial cell function. Br J Obstet Gynaecol 1997; 104: 235–240.
5. Smarason AK, Sargent IL, Redman CWG. Endothelial cell proliferation is suppressed by plasma but not serum from women with pre-eclampsia. Am J Obstet Gynecol 1996; 174: 787–793.
6. Chua S, Wilkins T, Sargent I, Redman C. Trophoblast deportation in pre-eclamptic pregnancy. Br J Obstet Gynecol 1991; 98: 973–979.
7. Jones CJP, Fox H. An ultrastructural and ultrahistochemical study of the human placenta in maternal pre-eclampsia. Placenta P 1980; 1: 61–76.
8. Khalfoun B, Degenne D, Crouzat-Reynes G, Bardos P. Effect of human syncytiotrophoblast plasma membrane-soluble extracts on in vitro mitogen-induced lymphocyte proliferation. A possible inhibition mechanism involving the transferrin receptor. J Immunol. 1986; 137: 1187–1192.
9. Mukkala V-M, Mikola H, Hemmila I. The synthesis and use of activated N-benzyl derivatives of diethylenetriaminetetraacetic acids: alternative reagents for labelling of antibodies with metalions. Anal. Biochem. 1989; 176: 319–325.
10. Sunderland CA, Redman CW, Stirrat GM. Monoclonal antibodies to human syncytiotrophoblast. Immunology 1981; 43: 541–546.
11. McLaughlin PJ, Cheng MH, Slade MB, Johnson PM. Expression on cultured human tumour cells of placental trophoblast membrane antigens and placental alkaline phosphatase defined by monoclonal antibodies. Int J Cancer 1982; 30: 21–6.
12. Contractor SF, Sooranna SR. Monoclonal antibodies to cytotrophoblast and syncytiotrophoblast of human placenta. J Dev Physiol 1986; 8: 277–282.
13. Durrant LG, McDowell KM, Holmes RA, Liu DT. Screening of monoclonal antibodies recognizing oncofetal antigens for isolation of trophoblasts from maternal blood for prenatal diagnosis. Prenat Diagn 1994; 14: 131–140.
14. World Health Organization Third Trophoblast Antigen and Monoclonal Antibody Workshop: Task force on birth control vaccines, 30 August, 1992, Rome, Italy.
15. Hsi B-L, Yeh C-J, Samson M, Fehlmann M. Monoclonal antibody GB36 raised against human trophoblast recognizes a novel epithelial antigen. Placenta 1987; 8: 209–217.
16. Anderson DJ, Johnson PM, Alexander NJ, Jones WR, Griffin PD. Monoclonal antibodies to trophoblast and sperm antigens: report of two WHO-sponsored workshops, June 30, 1986, Toronto, Canada. J Reprod Immunoll 1987; 10: 231–257.
17. Konijnenberg A, Stokkers EW, van der Post, JAM et al. Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules. Am J Obstet Gynecol 1997; 176: 461–9.
18. Smith CH, Nelson DM, King BF et al. Characterization of a microvillous membrane preparation from human placental syncytiotrophoblast: a morphologic, biochemical, and physiologic study. Am J Obstet Gynecol 1917, 128: 190–196.
19. Emerson DL, Arnaud P, Galbraith RM. Evidence of increased Gc:actin complexes in pregnant serum: a possible result of trophoblast embolism. Am J Reprod Immunol 1983; 4: 185–189.
20. Schrocksnadel H, Daxenbichler G, Artner E, Steckel-Berger G, Dapunt O. Tumour markers in hypertensive disorders of pregnancy. Gynecol Obstet Invest 1993; 35: 204–208.
21. Bremme K, Eneroth P, Nilsson B, Olsson M. Maternal and cord serum levels of tissue polypeptide antigen (TPA) in normal pregnancies. Gynecol Obstet Invest 1985; 19: 118–123.
22. Barden A, Graham D, Beilin LJ et al. Neutrophil CD IIb expression and neutrophil activation in pre-eclampsia. Clin Sci 1997; 92: 37–44.
23. Greer I, Haddad N, Dawes J, Johnstone F, Calder A. Neutrophil activation in pregnancy induced hypertension. Br J Obstet Gynaecol 1989; 96: 978–982.
24. Tsukimori K, Maeda H, Ishida K et al. The superoxide generation of neutrophils in normal and pre-eclamptic pregnancies. Obstet Gynecol 1993; 81: 536–540.
25. Greer IA, Lyall F, Perera T, Boswell F, Macara LM. Increased concentrations of interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction Obstet Gynecol 1994; 84: 931–940.
26. Vince G, Starkey P, Austgulen R, Kwiatkowski D, Redman C. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol 1995; 102: 20–25.